COPD Drug Development Summit

The inaugural COPD Drug Development Summit takes place from 15 to 17 September 2026 in Boston, MA, organised by Hanson Wade. After years of limited progress, COPD drug development is entering a pivotal moment, with the first biologic approval, renewed Big Pharma engagement and multi-billion-dollar deals reigniting interest in the field. The industry-led meeting convenes more than 65 senior experts from organisations including Johnson & Johnson, Sanofi, AstraZeneca, Merck, Ethris, Generate Biomedicines and Connect Biopharma, spanning discovery through late-stage development, with a focus on biomarker-driven trials, smarter trial design and more precise endpoints.